Real-world studies in complex treatments

Cisiv’s EDC platform, Baseline Plus, is built specifically to meet the complex needs of post-approval research.  Its flexible structure is well suited to oncology studies as it can adapt to very complex patient lifecycles and offers an intelligent and engaging online tool for both physicians and patients to enter study data.  It includes e-learning tools, a document library, and enables the entire study to be run in any language.

Please download the case study to learn more. 

More Case Studies

  • Designing and conducting a successful HEOR study

    A leading global pharmaceutical company was looking for a fit-for-purpose technology and methodology to...

  • Baseline Plus: Ideally suited for orphan drug post-approval studies

    Baseline Plus provided the ideal platform to enable a specialised European Pharma company to run a...

  • Optimising post-approval research: using technology for efficient and cost-effective studies

    A large global Pharma company was required to run a complex global safety study by regulatory authorities. This...

incisive solutions decisive results

©Cisiv 2016 - All Rights Reserved. Registered Company Number : 3110147

Website by 3Men²